Literature DB >> 15499545

Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.

Michael Brown1, Moses Kizza, Christine Watera, Maria A Quigley, Samantha Rowland, Peter Hughes, James A G Whitworth, Alison M Elliott.   

Abstract

BACKGROUND: We studied a cohort of human immunodeficiency virus (HIV)-infected adults in Uganda who were not receiving antiretroviral therapy, to explore the impact of helminths on HIV progression in areas where antiretrovirals are not available.
METHODS: A total of 663 patients were screened for helminths, treated presumptively with albendazole and selectively with praziquantel, and monitored for 6 months. Blood samples were analyzed for CD4+ cell count and HIV-1 RNA.
RESULTS: Schistosoma mansoni, hookworm, Strongyloides stercoralis, and Mansonella perstans were the most prevalent helminths. Helminth infection was not associated with higher viral load, lower CD4+ cell count, or faster decrease in CD4+ cell count preceding antihelminthic therapy. The effect of coinfection on HIV disease progression varied with species. CD4+ cell counts were highest in subjects with hookworm and Mansonella perstans infection. For most helminths, effective treatment was associated with greater decrease in CD4+ cell count than in those in whom infection was still present at follow-up. A highly significant decrease in viral load at 6 months was seen in patients with persistent Mansonella perstans infection at follow-up. Mortality was lower in subjects with hookworm infection at enrollment.
CONCLUSION: Helminth infection was not associated with more-advanced HIV disease or faster disease progression. Antihelminthic therapy may not be beneficial in slowing HIV progression in coinfected adults.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499545     DOI: 10.1086/425042

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

Review 1.  Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.

Authors:  Kayvon Modjarrad; Eric Chamot; Sten H Vermund
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

2.  Nodding Syndrome in the Spotlight - Placing Recent Findings in Perspective.

Authors:  Peter S Spencer; Erich Schmutzhard; Andrea S Winkler
Journal:  Trends Parasitol       Date:  2017-06-06

Review 3.  Species-specific treatment effects of helminth/HIV-1 co-infection: a systematic review and meta-analysis.

Authors:  Laura R Sangaré; Bradley R Herrin; Bradely R Herrin; Grace John-Stewart; Judd L Walson
Journal:  Parasitology       Date:  2011-05-18       Impact factor: 3.234

4.  Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection.

Authors:  Catherine A Blish; Laura Sangaré; Bradley R Herrin; Barbra A Richardson; Grace John-Stewart; Judd L Walson
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

5.  Strongyloidiasis-related deaths in the United States, 1991-2006.

Authors:  Curtis Croker; Roshan Reporter; Matt Redelings; Laurene Mascola
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

6.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.

Authors:  Judd L Walson; Phelgona A Otieno; Margaret Mbuchi; Barbra A Richardson; Barbara Lohman-Payne; Steve Wanyee Macharia; Julie Overbaugh; James Berkley; Eduard J Sanders; Michael H Chung; Grace C John-Stewart
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

7.  The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447].

Authors:  Alison M Elliott; Moses Kizza; Maria A Quigley; Juliet Ndibazza; Margaret Nampijja; Lawrence Muhangi; Linda Morison; Proscovia B Namujju; Moses Muwanga; Narcis Kabatereine; James A G Whitworth
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

8.  Risk factors for helminth, malaria, and HIV infection in pregnancy in Entebbe, Uganda.

Authors:  Patrick William Woodburn; Lawrence Muhangi; Stephen Hillier; Juliet Ndibazza; Proscovia Bazanya Namujju; Moses Kizza; Christine Ameke; Nicolas Emojong Omoding; Mark Booth; Alison Mary Elliott
Journal:  PLoS Negl Trop Dis       Date:  2009-06-30

9.  Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection.

Authors:  Mila Ayash-Rashkovsky; Agnès-Laurence Chenine; Lisa N Steele; Sandra J Lee; Ruijiang Song; Helena Ong; Robert A Rasmussen; Regina Hofmann-Lehmann; James G Else; Peter Augostini; Harold M McClure; W Evan Secor; Ruth M Ruprecht
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

10.  Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.

Authors:  Rbl Zinyama-Gutsire; E Gomo; P Kallestrup; C Erikstrup; H Ullum; A E Butterworth; S Munyati; T Mduluza
Journal:  BMC Infect Dis       Date:  2009-10-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.